Cargando…
Respiratory conditions in coronavirus disease 2019 (COVID-19): Important considerations regarding novel treatment strategies to reduce mortality
A novel virus named 2019 novel coronavirus (2019-nCoV/SARS-CoV-2) causes symptoms that are classified as coronavirus disease (COVID-19). Respiratory conditions are extensively described among more serious cases of COVID-19, and the onset of acute respiratory distress syndrome (ARDS) is one of the ha...
Autores principales: | Geier, Mark R., Geier, David A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175905/ https://www.ncbi.nlm.nih.gov/pubmed/32344310 http://dx.doi.org/10.1016/j.mehy.2020.109760 |
Ejemplares similares
-
Important considerations regarding the future management of coronavirus (COVID-19)
por: Abbas, Abdul-Rahman, et al.
Publicado: (2020) -
2019 Novel Coronavirus (COVID-19) Pandemic: Built Environment Considerations To Reduce Transmission
por: Dietz, Leslie, et al.
Publicado: (2020) -
A longitudinal ecological study of seasonal influenza deaths in relation to climate conditions in the United States from 1999 through 2011
por: Geier, David A., et al.
Publicado: (2018) -
A case–control study of quadrivalent human papillomavirus vaccine-associated autoimmune adverse events
por: Geier, David A., et al.
Publicado: (2014) -
Quadrivalent human papillomavirus vaccine and autoimmune adverse events: a case–control assessment of the vaccine adverse event reporting system (VAERS) database
por: Geier, David A., et al.
Publicado: (2016)